medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2018, Number 2

<< Back Next >>

Rev Mex Patol Clin Med Lab 2018; 65 (2)

Malignant hypercalcemia as a manifestation of metastatic germinal tumor in a patient with HIV infection

Fonseca-Mata JJ, Lara M, Romero-Cabello R, Romero-Feregrino R, Sánchez CJ

Language: Spanish
References: 13
Page: 113-117
PDF size: 301.13 Kb.


ABSTRACT

Germ cell tumors are neoplasms of primitive cells, there is a case of a 36-year-old male patient with human immunodeficiency virus infection, a treated seminoma presenting new tumor in right iliopsoas muscle, Mycobacterium tuberculosis were isolated, severe hypercalcemia with clinical neurological repercussion and, by biopsy and histochemical studies, metastasis of germinal tumor in psoas muscle. In this patient with its immunosuppression condition, the seminoma generated metastasis of germ cell tumors and the tubercolous infection, represented an important diagnostic challenge.


REFERENCES

  1. Goedert JJ, Purdue MP, McNeel TS, McGlynn KA, Engels EA. Risk of germ cell tumors among men with HIV/acquired immunodeficiency syndrome. Cancer Epidemiol Biomarkers Prev. 2007; 16 (6): 1266-1269.

  2. Wang CC, Silverberg MJ, Abrams DI. Non-AIDS-defining malignancies in the HIV-infected population. Curr Infect Dis Rep. 2014; 16 (6): 406.

  3. Bhavan KP, Kampalath VN, Overton ET. The aging of the HIV epidemic. Curr HIV/AIDS Rep. 2008; 5 (3): 150-158.

  4. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007; 370 (9581): 59-67.

  5. Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005; 97 (6): 425-432.

  6. Spano JP, Poizot-Martin I, Costagliola D, Boué F, Rosmorduc O, Lavolé A et al. Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group. Ann Oncol. 2016; 27 (3): 397-408.

  7. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005; 352 (4): 373-379.

  8. Mirrakhimov AE. Hypercalcemia of malignancy: an update on pathogenesis and management. N Am J Med Sci. 2015; 7 (11): 483-493.

  9. Rodríguez-Gutiérrez R, Zapata-Rivera MA, Quintanilla-Flores DL, Camara-Lemarroy CR, Lavalle-Gonzalez FJ, González-González JG et al. 1,25-dihydroxyvitamin D and PTHrP mediated malignant hypercalcemia in a seminoma. BMC Endocr Disord. 2014; 14: 32.

  10. Tong CV, Hussein Z, Noor NM, Mohamad M, Ng WF. Use of denosumab in parathyroid carcinoma with refractory hypercalcemia. QJM. 2015; 108 (1): 49-50.

  11. Torpy JM, Lynm C, Glass RM. JAMA patient page. Testicular cancer. JAMA. 2008; 299 (6): 718.

  12. Bosl GJ, Bajorin DF, Sheinfeld J et al. Cancer of the testis. En: DeVita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 7th ed. Philadelphia, Pa: Lippincott-Raven; 2005, pp. 1269-1293.

  13. Hanna N, Timmerman R, Foster RS et al. Testis cancer. En: Kufe DW, Pollock RE, Weichselbaum RR, Bast RC, Gansler TS, Holland JF eds. Cancer medicine. 6th ed. Hamilton, Ontario: BC Decker Inc.; 2003, pp. 1747-1768.




2020     |     www.medigraphic.com